The use of ethynylestradiol and medroxyprogesterone acetate to cause ovulation in women infertile due to approaching premature menopause
Buckler, H.M.; Petsos, P.; Newman, M.; Mamtora, H.; Anderson, D.C.
Journal of Endocrinology 108(Suppl)
1986
ISSN/ISBN: 0022-0795 Document Number: 463467
Document emailed within 1 workday
Related Documents
Sturm, G.; Antal, E.; Schmidt Rhode, P.; Bauer, T.; Schulz K D. 1986: Medroxyprogesterone acetate and immunoreactive medroxyprogesterone acetate metabolites measured by two different selective radioimmunoassay antibodies in medroxyprogesterone acetate treated breast cancer patients Anticancer Research 6(3 Part A): 362Archer, D.F.; Pickar, J.H.; Bottiglioni, F. 1994: Bleeding patterns in postmenopausal women taking continuous combined or sequential regimens of conjugated estrogens with medroxyprogesterone acetate. Menopause Study Group Obstetrics and Gynecology 83(5 Pt 1): 686-692
Zia, Y.; Tang, J.H.; Chinula, L.; Tegha, G.; Stanczyk, F.Z.; Kourtis, A.P. 2019: Medroxyprogesterone acetate concentrations among HIV-infected depot-medroxyprogesterone acetate users receiving antiretroviral therapy in Lilongwe, Malawi Contraception 100(5): 402-405
Blümel, J.E.; Roncagliolo, M.E.; Gramegna, G.; Vásquez, R.; Estartus, A.; Tacla, X.; Brandt, A. 1994: Double-blind method of the effect of menopause symptoms, lipid profile, and endometrial thickness of continuous therapy with estradiol valerate and medroxyprogesterone acetate Revista Chilena de Obstetricia y Ginecologia 59(5): 354-360
Boschitsch, E.; Gitsch, E.; Spona, J. 1983: Therapy of the surgical menopause syndrome with depot medroxyprogesterone acetate and its objective evaluation testing the reaction of the anterior pituitary gland to stimulation with gonadotropin-releasing hormone Wiener Klinische Wochenschrift 95(20): 718-724
Metcalf, M.G. 1983: Incidence of ovulation from the menarche to the menopause: observations of 622 New Zealand women New Zealand Medical Journal 96(738): 645-648
Jawalekar, K.S.; Chitale, M.V. 1973: Medroxyprogesterone acetate as an injectable contraceptive--its utility in Indian women Journal of Obstetrics and Gynaecology of India 23(1): 55-57
Sathyamala, C.; Shah, P.; Jain, Y.; Bhargava, A. 1994: Use of injectable depot medroxyprogesterone acetate in lactating Indian women Lancet 344(8915): 134-135
Cundy, T.; Cornish, J.; Evans, M.C.; Roberts, H.; Reid, I.R. 1994: Recovery of bone density in women who stop using medroxyprogesterone acetate Bmj 308(6923): 247-248
Sathyamala, C.; Shah, P.; Jain, Y.; Bhargava, A. 1994: Use of injectable depot medroxyprogesterone acetate in lactating Indian women Lancet 344(8915): 134-135
Frederiksen, M.C. 1996: Depot medroxyprogesterone acetate contraception in women with medical problems Journal of Reproductive Medicine 41(5 Suppl): 414-418
Sathyamala, C.; Shah, P.; Jain, Y.; Bhargava, A. 1994: Use of injectable depot medroxyprogesterone acetate in lactating Indian women Lancet 344(8915): 134-135
Heffron, R.; Mugo, N.; Were, E.; Kiarie, J.; Bukusi, E.A.; Mujugira, A.; Frenkel, L.M.; Donnell, D.; Ronald, A.; Celum, C.; Baeten, J.M.; Celum, C.; Baeten, J.M.; Donnell, D.; Coombs, R.W.; Frenkel, L.M.; Hendrix, C.W.; Lingappa, J.; McElrath, M..Juliana.; Fife, K.; Were, E.; Tumwesigye, E.; Katabira, E.; Katabira, E.; Bukusi, E.; Cohen, C.; Wangisi, J.; Campbell, J.; Tappero, J.; Kiarie, J.; Farquhar, C.; John-Stewart, G.; Mugo, N.Rwamba.; Campbell, J.; Tappero, J.; Wangisi, J. 2014: Preexposure prophylaxis is efficacious for HIV-1 prevention among women using depot medroxyprogesterone acetate for contraception Aids 28(18): 2771-2776
Ozgoli, G.; Sheikhan, Z.; Dolatian, M.; Simbar, M.; Bakhtyari, M.; Nasiri, M. 2015: Comparison of Sexual Dysfunction in Women Using Depo-Medroxyprogesterone Acetate (DMPA) and Cyclofem Journal of Reproduction and Infertility 16(2): 102-108
McDaniel, E.B.; Pardthaisong, T. 1973: Incidence of breast nodules in women receiving multiple doses of medroxyprogesterone acetate Journal of Biosocial Science 5(1): 83-88
Romer, A.; Shew, M.L.; Ofner, S.; Gilliam, M.L.; Martins, S.L.; Fortenberry, J.D. 2013: Depot medroxyprogesterone acetate use is not associated with risk of incident sexually transmitted infections among adolescent women Journal of Adolescent Health: Official Publication of the Society for Adolescent Medicine 52(1): 83-88
Nanda, K.; Morrison, C.S.; Kwok, C.; Byamugisha, J.; Jones, L.; Sriplienchan, S.; Magwali, T. 2011: Discontinuation of oral contraceptives and depot medroxyprogesterone acetate among women with and without HIV in Uganda, Zimbabwe and Thailand Contraception 83(6): 542-548
Overton, E.Turner.; Shacham, E.; Singhatiraj, E.; Nurutdinova, D. 2008: Incidence of sexually transmitted infections among HIV-infected women using depot medroxyprogesterone acetate contraception Contraception 78(2): 125-130
Gai, L.; Zhang, J.; Zhang, H.; Gai, P.; Liu, Y. 2009: Effect of Depot Medroxyprogesterone Acetate (DMPA) on Bone Mineral Density in Women of Reproductive Age Journal of Reproduction and Contraception 20(1): 51-56
Mannor, B.; Zohar, H. 2006: Sexual functioning and information needs in women with premature menopause following breast cancer treatment Harefuah 145(2): 90